EUVIMEDOpdag EUVIMED
Open access

Cryo-EM structures of human P2X2/3 heteromer channel reveal the structural basis of ligand selectivity

Xinyu Cheng iD, Wei Zhang, Tong Che iD, Hongmin Guo iD, Weiwei Nan, Yuting Zhang, Ying Fu iD, Shuangyan Wan, Jin Zhang iD

Science Advances · 2026-04-03 · 12 (14)

DOI: 10.1126/sciadv.aea9268 ↗

At a glance

Journal article in Science Advances, published on 2026-04-03. Written by Xinyu Cheng and 8 co-authors. Institution: The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, The Second Affiliated H…. Major MEDLINE topics: Cryoelectron Microscopy, Receptors, Purinergic P2X3, Receptors, Purinergic P2X2, Protein Multimerization. Cited 2 times so far (Crossref); 63 references. The full text is freely available in PubMed Central. Funded by: National Natural Science Foundation of China, CAS “Light of West China” Program, Jiangxi Province Natural Science Foundation.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

P2X3 receptors are key mediators of adenosine 5′-triphosphate (ATP)–evoked cough reflexes and validated drug targets, but first-generation antagonists such as gefapixant are limited by off-target inhibition of P2X2/3 heteromers in taste pathways. Here, we report the first cryo–electron microscopy (cryo-EM) structures of the human P2X2/3 heteromer in multiple ligand-bound states. The structures resolve its debated stoichiometries (1:2 and 2:1), reveal asymmetric pore organization, and identify heteromer-specific rearrangements that modulate ATP binding and gating. Structural and functional analyses show that gefapixant binds a conserved interfacial allosteric pocket, explaining its poor selectivity and taste-related side effects, whereas the next-generation antagonist camlipixant exploits a divergent vestibular site unique to P2X3, conferring >10,000-fold selectivity and improved tolerability. These findings establish a structural framework for P2X2/3 assembly and drug recognition and provide a roadmap for rational design of selective P2X modulators with enhanced safety and efficacy.

Subjects

MeSH terms (MEDLINE)

Cryoelectron MicroscopyReceptors, Purinergic P2X3Receptors, Purinergic P2X2Protein MultimerizationHumansLigandsAdenosine TriphosphateModels, MolecularProtein BindingProtein ConformationPurinergic P2X Receptor Antagonists

Substances

LigandsReceptors, Purinergic P2X3Receptors, Purinergic P2X2Adenosine TriphosphatePurinergic P2X Receptor Antagonists

Authors and institutions

  • The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiang…
  • Jiangxi Provincial Key Laboratory of Tumor Biology, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Shenzhen Crystalo Biopharmaceutical Co., Ltd., Shenzhen, Guangdong 518118, China.

ORCID profiles: Xinyu Cheng, Tong Che, Hongmin Guo, Ying Fu, Jin Zhang

Funding

  • National Natural Science Foundation of China
  • CAS “Light of West China” Program
  • Jiangxi Province Natural Science Foundation

Cite

APA

Cheng, X., Zhang, W., Che, T., Guo, H., Nan, W., Zhang, Y., Fu, Y., Wan, S., & Zhang, J. (2026). Cryo-EM structures of human P2X2/3 heteromer channel reveal the structural basis of ligand selectivity. Science Advances, 12(14). https://doi.org/10.1126/sciadv.aea9268

Vancouver

Cheng X, Zhang W, Che T, Guo H, Nan W, Zhang Y, et al. Cryo-EM structures of human P2X2/3 heteromer channel reveal the structural basis of ligand selectivity. Science Advances. 2026;12(14). doi:10.1126/sciadv.aea9268

BibTeX
@article{Cheng2026,
  author = {Cheng, Xinyu and Zhang, Wei and Che, Tong and Guo, Hongmin and Nan, Weiwei and Zhang, Yuting and Fu, Ying and Wan, Shuangyan and Zhang, Jin},
  title = {Cryo-EM structures of human P2X2/3 heteromer channel reveal the structural basis of ligand selectivity},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {14},
  doi = {10.1126/sciadv.aea9268}
}
Start for free →